The Swiss pharmaceutical firm says the acquisition would complement its current pipeline of therapies for neuromuscle problems.
Source link
Novartis Agrees to Acquire Avidity Biosciences for $12 Billion
Related Posts
How the AI Boom Is Leaving Consultants Behind
Consultants have lots to achieve serving to firms deploy probably the most transformative expertise in many years. Some shoppers say…
Best Noise Canceling Headphones – Buy Side
The Beats Studio Pro Wireless Headphones are an update to the popular Studio3 design. Although they look nearly identical, the…
SoFi stock drops on $1.5 billion stock offering
Anthony Noto, CEO of SoFi, talking with CNBC on the annual Allen & Co. Media and Expertise Convention in Solar…